Terms: = Head and neck cancer AND PR, PGR, progesterone receptor AND Clinical Outcome
26 results:
1. Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival.
Takano EA; Younes MM; Meehan K; Spalding L; Yan M; Allan P; Fox SB; Redfern A; Clouston D; Giles GG; Christie EL; Anderson RL; Zethoven M; Phillips KA; Gorringe K; Britt KL
BMC Cancer; 2023 May; 23(1):459. PubMed ID: 37208678
[TBL] [Abstract] [Full Text] [Related]
2. Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial.
Zhang G; Yuan J; Pan C; Xu Q; Cui X; Zhang J; Liu M; Song Z; Wu L; Wu D; Luo H; Hu Y; Jiao S; Yang B
EBioMedicine; 2023 Apr; 90():104515. PubMed ID: 36921563
[TBL] [Abstract] [Full Text] [Related]
3. Positive
Huang S; Qi M; Tian T; Dai H; Tang Y; Huang R
Front Endocrinol (Lausanne); 2022; 13():959089. PubMed ID: 36407316
[TBL] [Abstract] [Full Text] [Related]
4. clinical outcome in recurrent and/or metastatic head and neck cancer patients after discontinuation of nivolumab monotherapy due to immune-related adverse events.
Yasumatsu R; Matsuo M; Wakasaki T; Masuda M; Takeuchi T; Manako T; Jiromaru R; Uchi R; Hashimoto K; Nakagawa T
Acta Otolaryngol; 2020 Dec; 140(12):1043-1048. PubMed ID: 32808841
[TBL] [Abstract] [Full Text] [Related]
5. Endoscopic transorbital and endonasal approach for trigeminal schwannomas: a retrospective multicenter analysis (KOSEN-005).
Park HH; Hong SD; Kim YH; Hong CK; Woo KI; Yun IS; Kong DS
J Neurosurg; 2020 Aug; 133(2):467-476. PubMed ID: 31226689
[TBL] [Abstract] [Full Text] [Related]
6. Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy response.
Liu SL; Sun XS; Yan JJ; Chen QY; Lin HX; Wen YF; Guo SS; Liu LT; Xie HJ; Tang QN; Liang YJ; Li XY; Lin C; Du YY; Yang ZC; Xiao BB; Yang JH; Tang LQ; Guo L; Mai HQ
Radiother Oncol; 2019 Aug; 137():83-94. PubMed ID: 31078941
[TBL] [Abstract] [Full Text] [Related]
7. Adenoid cystic carcinomas of the salivary gland, lacrimal gland, and breast are morphologically and genetically similar but have distinct microRNA expression profiles.
Andreasen S; Tan Q; Agander TK; Steiner P; Bjørndal K; Høgdall E; Larsen SR; Erentaite D; Olsen CH; Ulhøi BP; von Holstein SL; Wessel I; Heegaard S; Homøe P
Mod Pathol; 2018 Aug; 31(8):1211-1225. PubMed ID: 29467480
[TBL] [Abstract] [Full Text] [Related]
8. The effect of photodynamic therapy with talaporfin sodium, a second-generation photosensitizer, on oral squamous cell carcinoma: A series of eight cases.
Ikeda H; Ohba S; Egashira K; Asahina I
Photodiagnosis Photodyn Ther; 2018 Mar; 21():176-180. PubMed ID: 29198764
[TBL] [Abstract] [Full Text] [Related]
9. The role of hepatic trans-arterial chemoembolization in metastatic medullary thyroid carcinoma: a specialist center experience and review of the literature.
Grozinsky-Glasberg S; Bloom AI; Lev-Cohain N; Klimov A; Besiso H; Gross DJ
Eur J Endocrinol; 2017 Apr; 176(4):463-470. PubMed ID: 28100632
[TBL] [Abstract] [Full Text] [Related]
10. clinical outcome in Definitive Concurrent Chemoradiation With Weekly Paclitaxel and Carboplatin for Locally Advanced Esophageal and Junctional cancer.
Noronha V; Prabhash K; Joshi A; Patil VM; Talole S; Nakti D; Sahu A; Shah S; Ghosh-Laskar S; Patil PS; Mehta SA; Jambhekar N; Mahajan A; Purandare N
Oncol Res; 2016; 23(4):183-95. PubMed ID: 27053347
[TBL] [Abstract] [Full Text] [Related]
11. Impact of pregnancy on prognosis of differentiated thyroid cancer: clinical and molecular features.
Messuti I; Corvisieri S; Bardesono F; Rapa I; Giorcelli J; Pellerito R; Volante M; Orlandi F
Eur J Endocrinol; 2014 May; 170(5):659-66. PubMed ID: 24510913
[TBL] [Abstract] [Full Text] [Related]
12. Expression of Bak and Bak/Mcl-1 ratio can predict photodynamic therapy outcome for oral verrucous hyperplasia and leukoplakia.
Yu CH; Chen HM; Lin HP; Chiang CP
J Oral Pathol Med; 2013 Mar; 42(3):257-62. PubMed ID: 22974427
[TBL] [Abstract] [Full Text] [Related]
13. Expression of the proliferation marker Ki-67 associates with tumour staging and clinical outcome in differentiated thyroid carcinomas.
Müssig K; Wehrmann T; Dittmann H; Wehrmann M; Ueberberg B; Schulz S; Bares R; Petersenn S
Clin Endocrinol (Oxf); 2012 Jul; 77(1):139-45. PubMed ID: 22248072
[TBL] [Abstract] [Full Text] [Related]
14. Expression of estrogen receptor, progesterone receptor, and vascular endothelial growth factor-A in thyroid cancer.
Kansakar E; Chang YJ; Mehrabi M; Mittal V
Am Surg; 2009 Sep; 75(9):785-9; discussion 789. PubMed ID: 19774949
[TBL] [Abstract] [Full Text] [Related]
15. Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127.
Dragovich T; McCoy S; Fenoglio-Preiser CM; Wang J; Benedetti JK; Baker AF; Hackett CB; Urba SG; Zaner KS; Blanke CD; Abbruzzese JL
J Clin Oncol; 2006 Oct; 24(30):4922-7. PubMed ID: 17050876
[TBL] [Abstract] [Full Text] [Related]
16. Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy.
Chen HM; Yu CH; Tu PC; Yeh CY; Tsai T; Chiang CP
Lasers Surg Med; 2005 Aug; 37(2):114-22. PubMed ID: 16037967
[TBL] [Abstract] [Full Text] [Related]
17. [Two head and neck cancer patients who responded to chemotherapy consisting of only TS-1].
Mikami Y; Tsukuda M; Kawai S; Kagesato Y; Tanigaki Y; Horiuchi C; Mochimatsu I
Gan To Kagaku Ryoho; 2003 Oct; 30(10):1473-7. PubMed ID: 14584280
[TBL] [Abstract] [Full Text] [Related]
18. Subcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters.
Mantovani G; Madeddu C; Gramignano G; Lusso MR; Mocci M; Massa E; Ferreli L; Astara G; Macciò A; Serpe R
J Exp Ther Oncol; 2003; 3(4):205-19. PubMed ID: 14567291
[TBL] [Abstract] [Full Text] [Related]
19. [clinical study in prophylactic use of chinese medicine to prevent chemoradiotherapy induced mucositis in nasopharyngeal carcinoma].
Huang GX; Zhao C; Han F; Zhang B; Qiu HJ; Xu BP; Chen XX; Hu PL
Ai Zheng; 2003 Oct; 22(10):1084-7. PubMed ID: 14558957
[TBL] [Abstract] [Full Text] [Related]
20. Six-week induction chemotherapy followed by concomitant chemoradiation therapy in stage IV head and neck cancer: a phase II study with organ-sparing purposes.
Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Ferreli L; Camboni P; Lusso MR; Mocci M; Madeddu C; Mura L; Mudu MC; Proto E; Tore G; Mura M; Macciò A; Ferreli A; Amichetti M
Oncol Rep; 2003; 10(3):759-66. PubMed ID: 12684655
[TBL] [Abstract] [Full Text] [Related]
[Next]
